Literature DB >> 6382576

Mechanisms of action of loperamide.

L A Ooms, A D Degryse, P A Janssen.   

Abstract

The pharmacology of loperamide is discussed, with particular reference to the drug's antidiarrhoeal properties. Its absorption, distribution, metabolism and excretion are considered and rapid concentration in the small intestine is described. The mechanism of action of loperamide on fluid and electrolyte transport is examined with reference to opiate agonism, calcium-channel blocking, calmodulin inhibition, and paracellular permeability. The colon appears to be the main site of action of loperamide on gut motility and transit. In the proximal colon, the drug accentuates segmenting motor activity. Work relating to the activity of loperamide on bacterial toxins and other secretory agents is outlined. Diarrhoea induced by prostaglandins can be prevented by pretreatment with the drug. Details are given of clinical applications of loperamide for diarrhoea control in children and adults. The drug has no significant side-effects and presents no serious threat of abuse.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6382576

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  22 in total

1.  The treatment of irritable bowel syndrome.

Authors:  Brian E Lacy; Kirsten Weiser; Ryan De Lee
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  mu-Opiate receptor agonists -- a new pharmacological approach to prevent motion sickness?

Authors:  Bärbel Otto; Rudolf L Riepl; Carsten Otto; Joachim Klose; Paul Enck; Sibylle Klosterhalfen
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

3.  Successful management of chronic high-output ileostomy with high dose loperamide.

Authors:  Alicia Mackowski; Han-Kuang Chen; Michael Levitt
Journal:  BMJ Case Rep       Date:  2015-04-22

4.  Effects of ketoconazole on the biodistribution and metabolism of [11C]loperamide and [11C]N-desmethyl-loperamide in wild-type and P-gp knockout mice.

Authors:  Nicholas Seneca; Sami S Zoghbi; H Umesha Shetty; Edward Tuan; Pavitra Kannan; Andrew Taku; Robert B Innis; Victor W Pike
Journal:  Nucl Med Biol       Date:  2010-04       Impact factor: 2.408

Review 5.  [Low anterior resection syndrome-Causes and treatment approaches].

Authors:  Sigmar Stelzner; Juliane Kupsch; Sören Torge Mees
Journal:  Chirurg       Date:  2021-04-20       Impact factor: 0.955

6.  Selective blockage of cell membrane K conductance by an antisecretory agent in guinea-pig gallbladder epithelium.

Authors:  F Wehner; J M Winterhager; K U Petersen
Journal:  Pflugers Arch       Date:  1989-07       Impact factor: 3.657

7.  Loperamide and oro-caecal transit delay.

Authors:  G Basilisco; G Camboni; A Bozzani; P A Bianchi
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

8.  Loperamide abolishes exercise-induced orocecal liquid transit acceleration.

Authors:  W F Keeling; A Harris; B J Martin
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

9.  Loperamide improves anal sphincter function and continence after restorative proctocolectomy.

Authors:  T Hallgren; S Fasth; D S Delbro; S Nordgren; T Oresland; L Hultén
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

10.  Loperamide mobilizes intracellular Ca2+ stores in insulin-secreting HIT-T15 cells.

Authors:  Li-Ping He; David Mears; Illani Atwater; Eduardo Rojas; Lars Cleemann
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.